|
|
|
Volumn 23, Issue 3 SUPPL. 6, 1996, Pages 78-83
|
|
Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: Preliminary results
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
IFOSFAMIDE;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADENOCARCINOMA;
ADULT;
AGED;
BLOOD TOXICITY;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SCREENING;
FEMALE;
HUMAN;
KIDNEY TUBULE ACIDOSIS;
LUNG NON SMALL CELL CANCER;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MESOTHELIOMA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG TOLERANCE;
FEMALE;
FILGRASTIM;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
IFOSFAMIDE;
LEUKOCYTE COUNT;
MALE;
MESNA;
MIDDLE AGED;
NEOPLASMS;
NEUTROPENIA;
NEUTROPHILS;
PACLITAXEL;
RECOMBINANT PROTEINS;
REMISSION INDUCTION;
|
|
EID: 0030013691
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
